Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 2:2019:5902091.
doi: 10.1155/2019/5902091. eCollection 2019.

Clinicopathological Characteristics and Prognosis of cT1N0M1 Gastric Cancer: A Population-Based Study

Jianbo Han  1 , Junhao Tu  2 , Chaoyang Tang  3 , Xiang Ma  3 , Chi Huang  4
Affiliations

Clinicopathological Characteristics and Prognosis of cT1N0M1 Gastric Cancer: A Population-Based Study

Jianbo Han et al. Dis Markers. .

Abstract

Background: Distant metastasis of early gastric cancer is a rare subgroup and poorly understood. The present study is aimed at summarizing the clinicopathological characteristics, prognosis, and management of clinical T1N0M1 (cT1N0M1) gastric cancer.

Method: Between 2004 and 2015, patients diagnosed with cT1N0M1 gastric cancer were retrospectively analyzed using the Surveillance, Epidemiology, and End Results (SEER) database.

Results: A total of 1093 cT1N0M1 gastric cancer patients were identified. 49 patients (4.5%) received cancer-directed surgery, and 113 patients (10.4%) were managed with radiotherapy. Compared with the other stage IV diseases, a relatively high proportion of black population (19.9% vs. 15.8%), patients older than 60 years (63.1% vs. 57.8%), and adenocarcinoma (59.5% vs. 55.9%) were observed in the cT1N0M1 gastric cancer subgroup. Besides that, patients with cT1N0M1 had the characteristics of less poor differentiated or undifferentiated (54.3% vs. 61.7%). Patients with cT1N0M1 had worse cancer-specific survival (CSS) and overall survival (OS) as compared to the other metastatic gastric cancer patients (CSS: p = 0.002, OS: p = 0.001 for log-rank test). Intriguingly, patients with cT1N0M1 had poor prognosis as compared to patients with cT1N+M1 (CSS: p = 0.015, OS: p = 0.007 for log-rank test). The 3-year and 5-year CSS for patients with cT1N0M1 were 5.7% and 4.0%, respectively. The addition of surgery resulted in improved CSS (p < 0.001 for log-rank test) while radiotherapy was not associated with CSS (p = 0.756 for log-rank test) in patients with cT1N0M1. A multivariate Cox analysis showed that surgery (HR = 0.378, 95% CI: 0.255-0.562) and patients younger than 60 (HR = 0.745, 95% CI: 0.647-0.858) years were independent protective factors for these subgroup patients.

Conclusion: Patients with cT1N0M1 gastric cancer had distinctive clinicopathological characteristics and presented poor prognosis. Knowledge of these differences contributes to guiding clinical evaluation for metastatic gastric cancer patients. More aggressive therapeutic strategy should be highlighted for this subgroup.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Kaplan-Meier survival curves revealed that patients with cT1N0M1 had worse cancer-specific survival and overall survival as compared to the other metastatic gastric cancer patients.
Figure 2
Figure 2
The Kaplan-Meier survival curves revealed that patients with cT1N0M1 had worse cancer-specific survival and overall survival as compared to patients with cT1N+M1.
Figure 3
Figure 3
The Kaplan-Meier survival curves revealed that the addition of surgery resulted in improved CSS while radiotherapy was not associated with cancer-specific survival in patients with cT1N0M1.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Wang Z., Ma L., Zhang X. M., Zhou Z. X. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China. Asian Pacific Journal of Cancer Prevention. 2014;15(17):7219–7222. doi: 10.7314/APJCP.2014.15.17.7219. - DOI - PubMed
    1. Choi I. J., Lee J. H., Kim Y. I., et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointestinal Endoscopy. 2015;81(2):333–341.e1. doi: 10.1016/j.gie.2014.07.047. - DOI - PubMed
    1. Yagi Y., Seshimo A., Kameoka S. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer. 2000;3(2):71–80. doi: 10.1007/PL00011699. - DOI - PubMed
    1. Lu J., Huang C. M., Zheng C. H., et al. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surgical Oncology. 2013;22(3):167–171. doi: 10.1016/j.suronc.2013.05.002. - DOI - PubMed